GSK3B and Alzheimer disease: We previously demonstrated that activation of Wnt signaling inhibits GSK-3β and leads to neuroprotection in both hippocampal cultured neurons and in vivo transgenic model of AD (Alvarez et al., 2004; Quintanilla et al., 2005; Toledo and Inestrosa, 2010).